Summary
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
According to APO Research, The global Anti-Venom market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Anti-Venom is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Anti-Venom is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Anti-Venom is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Anti-Venom is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Anti-Venom include CSL, Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts and Bharat Serums and Vaccines, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Anti-Venom, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anti-Venom, also provides the sales of main regions and countries. Of the upcoming market potential for Anti-Venom, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-Venom sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-Venom market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anti-Venom sales, projected growth trends, production technology, application and end-user industry.
Anti-Venom segment by Company
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Anti-Venom segment by Type
Polyvalent Anti-Venom
Monovalent Anti-Venom
Anti-Venom segment by Application
Non-profit Institutions
Hospitals and Clinic
Anti-Venom segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Venom market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Venom and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Venom.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Anti-Venom in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Anti-Venom manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Venom sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Anti-Venom Market by Type
1.2.1 Global Anti-Venom Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Polyvalent Anti-Venom
1.2.3 Monovalent Anti-Venom
1.3 Anti-Venom Market by Application
1.3.1 Global Anti-Venom Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Anti-Venom Market Dynamics
2.1 Anti-Venom Industry Trends
2.2 Anti-Venom Industry Drivers
2.3 Anti-Venom Industry Opportunities and Challenges
2.4 Anti-Venom Industry Restraints
3 Global Market Growth Prospects
3.1 Global Anti-Venom Revenue Estimates and Forecasts (2019-2030)
3.2 Global Anti-Venom Revenue by Region
3.2.1 Global Anti-Venom Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Anti-Venom Revenue by Region (2019-2024)
3.2.3 Global Anti-Venom Revenue by Region (2025-2030)
3.2.4 Global Anti-Venom Revenue Market Share by Region (2019-2030)
3.3 Global Anti-Venom Sales Estimates and Forecasts 2019-2030
3.4 Global Anti-Venom Sales by Region
3.4.1 Global Anti-Venom Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Anti-Venom Sales by Region (2019-2024)
3.4.3 Global Anti-Venom Sales by Region (2025-2030)
3.4.4 Global Anti-Venom Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Anti-Venom Revenue by Manufacturers
4.1.1 Global Anti-Venom Revenue by Manufacturers (2019-2024)
4.1.2 Global Anti-Venom Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Anti-Venom Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Anti-Venom Sales by Manufacturers
4.2.1 Global Anti-Venom Sales by Manufacturers (2019-2024)
4.2.2 Global Anti-Venom Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Anti-Venom Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Anti-Venom Sales Price by Manufacturers (2019-2024)
4.4 Global Anti-Venom Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Anti-Venom Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Anti-Venom Manufacturers, Product Type & Application
4.7 Global Anti-Venom Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Anti-Venom Market CR5 and HHI
4.8.2 2023 Anti-Venom Tier 1, Tier 2, and Tier 3
5 Anti-Venom Market by Type
5.1 Global Anti-Venom Revenue by Type
5.1.1 Global Anti-Venom Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Anti-Venom Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Anti-Venom Revenue Market Share by Type (2019-2030)
5.2 Global Anti-Venom Sales by Type
5.2.1 Global Anti-Venom Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Anti-Venom Sales by Type (2019-2030) & (K Vials)
5.2.3 Global Anti-Venom Sales Market Share by Type (2019-2030)
5.3 Global Anti-Venom Price by Type
6 Anti-Venom Market by Application
6.1 Global Anti-Venom Revenue by Application
6.1.1 Global Anti-Venom Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Anti-Venom Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Anti-Venom Revenue Market Share by Application (2019-2030)
6.2 Global Anti-Venom Sales by Application
6.2.1 Global Anti-Venom Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Anti-Venom Sales by Application (2019-2030) & (K Vials)
6.2.3 Global Anti-Venom Sales Market Share by Application (2019-2030)
6.3 Global Anti-Venom Price by Application
7 Company Profiles
7.1 CSL
7.1.1 CSL Comapny Information
7.1.2 CSL Business Overview
7.1.3 CSL Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 CSL Anti-Venom Product Portfolio
7.1.5 CSL Recent Developments
7.2 Merck
7.2.1 Merck Comapny Information
7.2.2 Merck Business Overview
7.2.3 Merck Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Merck Anti-Venom Product Portfolio
7.2.5 Merck Recent Developments
7.3 BTG
7.3.1 BTG Comapny Information
7.3.2 BTG Business Overview
7.3.3 BTG Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 BTG Anti-Venom Product Portfolio
7.3.5 BTG Recent Developments
7.4 Pfizer
7.4.1 Pfizer Comapny Information
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Pfizer Anti-Venom Product Portfolio
7.4.5 Pfizer Recent Developments
7.5 Haffkine Bio-Pharmaceutical
7.5.1 Haffkine Bio-Pharmaceutical Comapny Information
7.5.2 Haffkine Bio-Pharmaceutical Business Overview
7.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Product Portfolio
7.5.5 Haffkine Bio-Pharmaceutical Recent Developments
7.6 Rare Disease Therapeutics
7.6.1 Rare Disease Therapeutics Comapny Information
7.6.2 Rare Disease Therapeutics Business Overview
7.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Rare Disease Therapeutics Anti-Venom Product Portfolio
7.6.5 Rare Disease Therapeutics Recent Developments
7.7 Flynn Pharma
7.7.1 Flynn Pharma Comapny Information
7.7.2 Flynn Pharma Business Overview
7.7.3 Flynn Pharma Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Flynn Pharma Anti-Venom Product Portfolio
7.7.5 Flynn Pharma Recent Developments
7.8 Vins Bioproducts
7.8.1 Vins Bioproducts Comapny Information
7.8.2 Vins Bioproducts Business Overview
7.8.3 Vins Bioproducts Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 Vins Bioproducts Anti-Venom Product Portfolio
7.8.5 Vins Bioproducts Recent Developments
7.9 Bharat Serums and Vaccines
7.9.1 Bharat Serums and Vaccines Comapny Information
7.9.2 Bharat Serums and Vaccines Business Overview
7.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Bharat Serums and Vaccines Anti-Venom Product Portfolio
7.9.5 Bharat Serums and Vaccines Recent Developments
7.10 Serum Biotech
7.10.1 Serum Biotech Comapny Information
7.10.2 Serum Biotech Business Overview
7.10.3 Serum Biotech Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Serum Biotech Anti-Venom Product Portfolio
7.10.5 Serum Biotech Recent Developments
7.11 MicroPharm
7.11.1 MicroPharm Comapny Information
7.11.2 MicroPharm Business Overview
7.11.3 MicroPharm Anti-Venom Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 MicroPharm Anti-Venom Product Portfolio
7.11.5 MicroPharm Recent Developments
8 North America
8.1 North America Anti-Venom Market Size by Type
8.1.1 North America Anti-Venom Revenue by Type (2019-2030)
8.1.2 North America Anti-Venom Sales by Type (2019-2030)
8.1.3 North America Anti-Venom Price by Type (2019-2030)
8.2 North America Anti-Venom Market Size by Application
8.2.1 North America Anti-Venom Revenue by Application (2019-2030)
8.2.2 North America Anti-Venom Sales by Application (2019-2030)
8.2.3 North America Anti-Venom Price by Application (2019-2030)
8.3 North America Anti-Venom Market Size by Country
8.3.1 North America Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Anti-Venom Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Anti-Venom Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Anti-Venom Market Size by Type
9.1.1 Europe Anti-Venom Revenue by Type (2019-2030)
9.1.2 Europe Anti-Venom Sales by Type (2019-2030)
9.1.3 Europe Anti-Venom Price by Type (2019-2030)
9.2 Europe Anti-Venom Market Size by Application
9.2.1 Europe Anti-Venom Revenue by Application (2019-2030)
9.2.2 Europe Anti-Venom Sales by Application (2019-2030)
9.2.3 Europe Anti-Venom Price by Application (2019-2030)
9.3 Europe Anti-Venom Market Size by Country
9.3.1 Europe Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Anti-Venom Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Anti-Venom Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Anti-Venom Market Size by Type
10.1.1 China Anti-Venom Revenue by Type (2019-2030)
10.1.2 China Anti-Venom Sales by Type (2019-2030)
10.1.3 China Anti-Venom Price by Type (2019-2030)
10.2 China Anti-Venom Market Size by Application
10.2.1 China Anti-Venom Revenue by Application (2019-2030)
10.2.2 China Anti-Venom Sales by Application (2019-2030)
10.2.3 China Anti-Venom Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Anti-Venom Market Size by Type
11.1.1 Asia Anti-Venom Revenue by Type (2019-2030)
11.1.2 Asia Anti-Venom Sales by Type (2019-2030)
11.1.3 Asia Anti-Venom Price by Type (2019-2030)
11.2 Asia Anti-Venom Market Size by Application
11.2.1 Asia Anti-Venom Revenue by Application (2019-2030)
11.2.2 Asia Anti-Venom Sales by Application (2019-2030)
11.2.3 Asia Anti-Venom Price by Application (2019-2030)
11.3 Asia Anti-Venom Market Size by Country
11.3.1 Asia Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Anti-Venom Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Anti-Venom Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Anti-Venom Market Size by Type
12.1.1 MEALA Anti-Venom Revenue by Type (2019-2030)
12.1.2 MEALA Anti-Venom Sales by Type (2019-2030)
12.1.3 MEALA Anti-Venom Price by Type (2019-2030)
12.2 MEALA Anti-Venom Market Size by Application
12.2.1 MEALA Anti-Venom Revenue by Application (2019-2030)
12.2.2 MEALA Anti-Venom Sales by Application (2019-2030)
12.2.3 MEALA Anti-Venom Price by Application (2019-2030)
12.3 MEALA Anti-Venom Market Size by Country
12.3.1 MEALA Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Anti-Venom Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Anti-Venom Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Anti-Venom Value Chain Analysis
13.1.1 Anti-Venom Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Anti-Venom Production Mode & Process
13.2 Anti-Venom Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Anti-Venom Distributors
13.2.3 Anti-Venom Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Anti-Venom Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Polyvalent Anti-Venom Major Manufacturers
Table 3. Monovalent Anti-Venom Major Manufacturers
Table 4. Global Anti-Venom Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Non-profit Institutions Major Manufacturers
Table 6. Hospitals and Clinic Major Manufacturers
Table 7. Anti-Venom Industry Trends
Table 8. Anti-Venom Industry Drivers
Table 9. Anti-Venom Industry Opportunities and Challenges
Table 10. Anti-Venom Industry Restraints
Table 11. Global Anti-Venom Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Anti-Venom Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Anti-Venom Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Anti-Venom Revenue Market Share by Region (2019-2024)
Table 15. Global Anti-Venom Revenue Market Share by Region (2025-2030)
Table 16. Global Anti-Venom Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Vials)
Table 17. Global Anti-Venom Sales by Region (2019-2024) & (K Vials)
Table 18. Global Anti-Venom Sales by Region (2025-2030) & (K Vials)
Table 19. Global Anti-Venom Sales Market Share by Region (2019-2024)
Table 20. Global Anti-Venom Sales Market Share by Region (2025-2030)
Table 21. Global Anti-Venom Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Anti-Venom Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Anti-Venom Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Anti-Venom Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Anti-Venom Sales Price (USD/Vial) of Manufacturers (2019-2024)
Table 26. Global Anti-Venom Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Anti-Venom Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Anti-Venom Manufacturers, Product Type & Application
Table 29. Global Anti-Venom Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Anti-Venom by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Anti-Venom Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Anti-Venom Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Anti-Venom Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Anti-Venom Revenue Market Share by Type (2019-2024)
Table 36. Global Anti-Venom Revenue Market Share by Type (2025-2030)
Table 37. Global Anti-Venom Sales by Type 2019 VS 2023 VS 2030 (K Vials)
Table 38. Global Anti-Venom Sales by Type (2019-2024) & (K Vials)
Table 39. Global Anti-Venom Sales by Type (2025-2030) & (K Vials)
Table 40. Global Anti-Venom Sales Market Share by Type (2019-2024)
Table 41. Global Anti-Venom Sales Market Share by Type (2025-2030)
Table 42. Global Anti-Venom Price by Type (2019-2024) & (USD/Vial)
Table 43. Global Anti-Venom Price by Type (2025-2030) & (USD/Vial)
Table 44. Global Anti-Venom Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Anti-Venom Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Anti-Venom Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Anti-Venom Revenue Market Share by Application (2019-2024)
Table 48. Global Anti-Venom Revenue Market Share by Application (2025-2030)
Table 49. Global Anti-Venom Sales by Application 2019 VS 2023 VS 2030 (K Vials)
Table 50. Global Anti-Venom Sales by Application (2019-2024) & (K Vials)
Table 51. Global Anti-Venom Sales by Application (2025-2030) & (K Vials)
Table 52. Global Anti-Venom Sales Market Share by Application (2019-2024)
Table 53. Global Anti-Venom Sales Market Share by Application (2025-2030)
Table 54. Global Anti-Venom Price by Application (2019-2024) & (USD/Vial)
Table 55. Global Anti-Venom Price by Application (2025-2030) & (USD/Vial)
Table 56. CSL Company Information
Table 57. CSL Business Overview
Table 58. CSL Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 59. CSL Anti-Venom Product Portfolio
Table 60. CSL Recent Development
Table 61. Merck Company Information
Table 62. Merck Business Overview
Table 63. Merck Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 64. Merck Anti-Venom Product Portfolio
Table 65. Merck Recent Development
Table 66. BTG Company Information
Table 67. BTG Business Overview
Table 68. BTG Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 69. BTG Anti-Venom Product Portfolio
Table 70. BTG Recent Development
Table 71. Pfizer Company Information
Table 72. Pfizer Business Overview
Table 73. Pfizer Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 74. Pfizer Anti-Venom Product Portfolio
Table 75. Pfizer Recent Development
Table 76. Haffkine Bio-Pharmaceutical Company Information
Table 77. Haffkine Bio-Pharmaceutical Business Overview
Table 78. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 79. Haffkine Bio-Pharmaceutical Anti-Venom Product Portfolio
Table 80. Haffkine Bio-Pharmaceutical Recent Development
Table 81. Rare Disease Therapeutics Company Information
Table 82. Rare Disease Therapeutics Business Overview
Table 83. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 84. Rare Disease Therapeutics Anti-Venom Product Portfolio
Table 85. Rare Disease Therapeutics Recent Development
Table 86. Flynn Pharma Company Information
Table 87. Flynn Pharma Business Overview
Table 88. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 89. Flynn Pharma Anti-Venom Product Portfolio
Table 90. Flynn Pharma Recent Development
Table 91. Vins Bioproducts Company Information
Table 92. Vins Bioproducts Business Overview
Table 93. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 94. Vins Bioproducts Anti-Venom Product Portfolio
Table 95. Vins Bioproducts Recent Development
Table 96. Bharat Serums and Vaccines Company Information
Table 97. Bharat Serums and Vaccines Business Overview
Table 98. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 99. Bharat Serums and Vaccines Anti-Venom Product Portfolio
Table 100. Bharat Serums and Vaccines Recent Development
Table 101. Serum Biotech Company Information
Table 102. Serum Biotech Business Overview
Table 103. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 104. Serum Biotech Anti-Venom Product Portfolio
Table 105. Serum Biotech Recent Development
Table 106. MicroPharm Company Information
Table 107. MicroPharm Business Overview
Table 108. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$ Million), Price (USD/Vial) and Gross Margin (2019-2024)
Table 109. MicroPharm Anti-Venom Product Portfolio
Table 110. MicroPharm Recent Development
Table 111. North America Anti-Venom Revenue by Type (2019-2024) & (US$ Million)
Table 112. North America Anti-Venom Revenue by Type (2025-2030) & (US$ Million)
Table 113. North America Anti-Venom Sales by Type (2019-2024) & (K Vials)
Table 114. North America Anti-Venom Sales by Type (2025-2030) & (K Vials)
Table 115. North America Anti-Venom Sales Price by Type (2019-2024) & (USD/Vial)
Table 116. North America Anti-Venom Sales Price by Type (2025-2030) & (USD/Vial)
Table 117. North America Anti-Venom Revenue by Application (2019-2024) & (US$ Million)
Table 118. North America Anti-Venom Revenue by Application (2025-2030) & (US$ Million)
Table 119. North America Anti-Venom Sales by Application (2019-2024) & (K Vials)
Table 120. North America Anti-Venom Sales by Application (2025-2030) & (K Vials)
Table 121. North America Anti-Venom Sales Price by Application (2019-2024) & (USD/Vial)
Table 122. North America Anti-Venom Sales Price by Application (2025-2030) & (USD/Vial)
Table 123. North America Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 124. North America Anti-Venom Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 125. North America Anti-Venom Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 126. North America Anti-Venom Sales by Country (2019 VS 2023 VS 2030) & (K Vials)
Table 127. North America Anti-Venom Sales by Country (2019-2024) & (K Vials)
Table 128. North America Anti-Venom Sales by Country (2025-2030) & (K Vials)
Table 129. North America Anti-Venom Sales Price by Country (2019-2024) & (USD/Vial)
Table 130. North America Anti-Venom Sales Price by Country (2025-2030) & (USD/Vial)
Table 131. US Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 132. Canada Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 133. Europe Anti-Venom Revenue by Type (2019-2024) & (US$ Million)
Table 134. Europe Anti-Venom Revenue by Type (2025-2030) & (US$ Million)
Table 135. Europe Anti-Venom Sales by Type (2019-2024) & (K Vials)
Table 136. Europe Anti-Venom Sales by Type (2025-2030) & (K Vials)
Table 137. Europe Anti-Venom Sales Price by Type (2019-2024) & (USD/Vial)
Table 138. Europe Anti-Venom Sales Price by Type (2025-2030) & (USD/Vial)
Table 139. Europe Anti-Venom Revenue by Application (2019-2024) & (US$ Million)
Table 140. Europe Anti-Venom Revenue by Application (2025-2030) & (US$ Million)
Table 141. Europe Anti-Venom Sales by Application (2019-2024) & (K Vials)
Table 142. Europe Anti-Venom Sales by Application (2025-2030) & (K Vials)
Table 143. Europe Anti-Venom Sales Price by Application (2019-2024) & (USD/Vial)
Table 144. Europe Anti-Venom Sales Price by Application (2025-2030) & (USD/Vial)
Table 145. Europe Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 146. Europe Anti-Venom Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 147. Europe Anti-Venom Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 148. Europe Anti-Venom Sales by Country (2019 VS 2023 VS 2030) & (K Vials)
Table 149. Europe Anti-Venom Sales by Country (2019-2024) & (K Vials)
Table 150. Europe Anti-Venom Sales by Country (2025-2030) & (K Vials)
Table 151. Europe Anti-Venom Sales Price by Country (2019-2024) & (USD/Vial)
Table 152. Europe Anti-Venom Sales Price by Country (2025-2030) & (USD/Vial)
Table 153. Germany Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 154. France Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 155. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 156. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 157. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 158. China Anti-Venom Revenue by Type (2019-2024) & (US$ Million)
Table 159. China Anti-Venom Revenue by Type (2025-2030) & (US$ Million)
Table 160. China Anti-Venom Sales by Type (2019-2024) & (K Vials)
Table 161. China Anti-Venom Sales by Type (2025-2030) & (K Vials)
Table 162. China Anti-Venom Sales Price by Type (2019-2024) & (USD/Vial)
Table 163. China Anti-Venom Sales Price by Type (2025-2030) & (USD/Vial)
Table 164. China Anti-Venom Revenue by Application (2019-2024) & (US$ Million)
Table 165. China Anti-Venom Revenue by Application (2025-2030) & (US$ Million)
Table 166. China Anti-Venom Sales by Application (2019-2024) & (K Vials)
Table 167. China Anti-Venom Sales by Application (2025-2030) & (K Vials)
Table 168. China Anti-Venom Sales Price by Application (2019-2024) & (USD/Vial)
Table 169. China Anti-Venom Sales Price by Application (2025-2030) & (USD/Vial)
Table 170. Asia Anti-Venom Revenue by Type (2019-2024) & (US$ Million)
Table 171. Asia Anti-Venom Revenue by Type (2025-2030) & (US$ Million)
Table 172. Asia Anti-Venom Sales by Type (2019-2024) & (K Vials)
Table 173. Asia Anti-Venom Sales by Type (2025-2030) & (K Vials)
Table 174. Asia Anti-Venom Sales Price by Type (2019-2024) & (USD/Vial)
Table 175. Asia Anti-Venom Sales Price by Type (2025-2030) & (USD/Vial)
Table 176. Asia Anti-Venom Revenue by Application (2019-2024) & (US$ Million)
Table 177. Asia Anti-Venom Revenue by Application (2025-2030) & (US$ Million)
Table 178. Asia Anti-Venom Sales by Application (2019-2024) & (K Vials)
Table 179. Asia Anti-Venom Sales by Application (2025-2030) & (K Vials)
Table 180. Asia Anti-Venom Sales Price by Application (2019-2024) & (USD/Vial)
Table 181. Asia Anti-Venom Sales Price by Application (2025-2030) & (USD/Vial)
Table 182. Asia Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 183. Asia Anti-Venom Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 184. Asia Anti-Venom Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 185. Asia Anti-Venom Sales by Country (2019 VS 2023 VS 2030) & (K Vials)
Table 186. Asia Anti-Venom Sales by Country (2019-2024) & (K Vials)
Table 187. Asia Anti-Venom Sales by Country (2025-2030) & (K Vials)
Table 188. Asia Anti-Venom Sales Price by Country (2019-2024) & (USD/Vial)
Table 189. Asia Anti-Venom Sales Price by Country (2025-2030) & (USD/Vial)
Table 190. Japan Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 191. South Korea Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 192. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 193. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 194. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 195. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 196. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 197. Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 198. MEALA Anti-Venom Revenue by Type (2019-2024) & (US$ Million)
Table 199. MEALA Anti-Venom Revenue by Type (2025-2030) & (US$ Million)
Table 200. MEALA Anti-Venom Sales by Type (2019-2024) & (K Vials)
Table 201. MEALA Anti-Venom Sales by Type (2025-2030) & (K Vials)
Table 202. MEALA Anti-Venom Sales Price by Type (2019-2024) & (USD/Vial)
Table 203. MEALA Anti-Venom Sales Price by Type (2025-2030) & (USD/Vial)
Table 204. MEALA Anti-Venom Revenue by Application (2019-2024) & (US$ Million)
Table 205. MEALA Anti-Venom Revenue by Application (2025-2030) & (US$ Million)
Table 206. MEALA Anti-Venom Sales by Application (2019-2024) & (K Vials)
Table 207. MEALA Anti-Venom Sales by Application (2025-2030) & (K Vials)
Table 208. MEALA Anti-Venom Sales Price by Application (2019-2024) & (USD/Vial)
Table 209. MEALA Anti-Venom Sales Price by Application (2025-2030) & (USD/Vial)
Table 210. MEALA Anti-Venom Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 211. MEALA Anti-Venom Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 212. MEALA Anti-Venom Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 213. MEALA Anti-Venom Sales by Country (2019 VS 2023 VS 2030) & (K Vials)
Table 214. MEALA Anti-Venom Sales by Country (2019-2024) & (K Vials)
Table 215. MEALA Anti-Venom Sales by Country (2025-2030) & (K Vials)
Table 216. MEALA Anti-Venom Sales Price by Country (2019-2024) & (USD/Vial)
Table 217. MEALA Anti-Venom Sales Price by Country (2025-2030) & (USD/Vial)
Table 218. Mexico Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 219. Brazil Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 220. Israel Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 221. Argentina Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 222. Colombia Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 223. Turkey Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 224. Saudi Arabia Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 225. UAE Anti-Venom Revenue (2019-2030) & (US$ Million)
Table 226. Key Raw Materials
Table 227. Raw Materials Key Suppliers
Table 228. Anti-Venom Distributors List
Table 229. Anti-Venom Customers List
Table 230. Research Programs/Design for This Report
Table 231. Authors List of This Report
Table 232. Secondary Sources
Table 233. Primary Sources
List of Figures
Figure 1. Anti-Venom Product Picture
Figure 2. Global Anti-Venom Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Anti-Venom Market Size Share 2019 VS 2023 VS 2030
Figure 4. Polyvalent Anti-Venom Picture
Figure 5. Monovalent Anti-Venom Picture
Figure 6. Global Anti-Venom Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Anti-Venom Market Size Share 2019 VS 2023 VS 2030
Figure 8. Non-profit Institutions Picture
Figure 9. Hospitals and Clinic Picture
Figure 10. Global Anti-Venom Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Anti-Venom Revenue (2019-2030) & (US$ Million)
Figure 12. Global Anti-Venom Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Anti-Venom Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Anti-Venom Revenue Market Share by Region (2019-2030)
Figure 15. Global Anti-Venom Sales (2019-2030) & (K Vials)
Figure 16. Global Anti-Venom Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Vials)
Figure 17. Global Anti-Venom Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Anti-Venom Sales YoY (2019-2030) & (K Vials)
Figure 19. Europe Anti-Venom Sales YoY (2019-2030) & (K Vials)
Figure 20. China Anti-Venom Sales YoY (2019-2030) & (K Vials)
Figure 21. Asia (Excluding China) Anti-Venom Sales YoY (2019-2030) & (K Vials)
Figure 22. Middle East, Africa and Latin America (Excluding China) Anti-Venom Sales YoY (2019-2030) & (K Vials)
Figure 23. Global Anti-Venom Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Anti-Venom Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Anti-Venom Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Anti-Venom Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Anti-Venom Revenue Market Share by Type (2019-2030)
Figure 29. Global Anti-Venom Sales by Type (2019 VS 2023 VS 2030) & (K Vials)
Figure 30. Global Anti-Venom Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Anti-Venom Sales Market Share by Type (2019-2030)
Figure 32. Global Anti-Venom Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Anti-Venom Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Anti-Venom Revenue Market Share by Application (2019-2030)
Figure 35. Global Anti-Venom Sales by Application (2019 VS 2023 VS 2030) & (K Vials)
Figure 36. Global Anti-Venom Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Anti-Venom Sales Market Share by Application (2019-2030)
Figure 38. North America Anti-Venom Revenue Share by Type (2019-2030)
Figure 39. North America Anti-Venom Sales Share by Type (2019-2030)
Figure 40. North America Anti-Venom Revenue Share by Application (2019-2030)
Figure 41. North America Anti-Venom Sales Share by Application (2019-2030)
Figure 42. North America Anti-Venom Revenue Share by Country (2019-2030)
Figure 43. North America Anti-Venom Sales Share by Country (2019-2030)
Figure 44. Europe Anti-Venom Revenue Share by Type (2019-2030)
Figure 45. Europe Anti-Venom Sales Share by Type (2019-2030)
Figure 46. Europe Anti-Venom Revenue Share by Application (2019-2030)
Figure 47. Europe Anti-Venom Sales Share by Application (2019-2030)
Figure 48. Europe Anti-Venom Revenue Share by Country (2019-2030)
Figure 49. Europe Anti-Venom Sales Share by Country (2019-2030)
Figure 50. China Anti-Venom Revenue Share by Type (2019-2030)
Figure 51. China Anti-Venom Sales Share by Type (2019-2030)
Figure 52. China Anti-Venom Revenue Share by Application (2019-2030)
Figure 53. China Anti-Venom Sales Share by Application (2019-2030)
Figure 54. Asia Anti-Venom Revenue Share by Type (2019-2030)
Figure 55. Asia Anti-Venom Sales Share by Type (2019-2030)
Figure 56. Asia Anti-Venom Revenue Share by Application (2019-2030)
Figure 57. Asia Anti-Venom Sales Share by Application (2019-2030)
Figure 58. Asia Anti-Venom Revenue Share by Country (2019-2030)
Figure 59. Asia Anti-Venom Sales Share by Country (2019-2030)
Figure 60. MEALA Anti-Venom Revenue Share by Type (2019-2030)
Figure 61. MEALA Anti-Venom Sales Share by Type (2019-2030)
Figure 62. MEALA Anti-Venom Revenue Share by Application (2019-2030)
Figure 63. MEALA Anti-Venom Sales Share by Application (2019-2030)
Figure 64. MEALA Anti-Venom Revenue Share by Country (2019-2030)
Figure 65. MEALA Anti-Venom Sales Share by Country (2019-2030)
Figure 66. Anti-Venom Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Anti-Venom Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
